Gallbladder disease: Cholelithiasis (gallstones) and cholecystitis have been reported with GLP-1 receptor agonist therapies and may also occur with rapid weight loss
The dose-response curve between 8 and 12 mg shows diminishing returns, meaning 10 mg captures most of the benefit while potentially reducing some of the dose-related side effects seen at 12 mg
It's essential to be patient and consistent with your medication regimen and lifestyle changes to achieve optimal results
Significant Weight Loss Retatrutide has demonstrated remarkable weight loss in clinical trials, with participants achieving up to 24% body weight loss over 48 weeks at higher doses
E., Wolski, K., Feng, Q., Gyongyosi, M., Lscher, T
Circulation 145 , e722e759 (2022)